CJC-1295 + Ipamorelin – Overview & Benefits
We aim to simplify peptide research by offering:
The combination of CJC-1295 (a GHRH analog) and Ipamorelin (a GHRP) provides one of the most
effective ways to naturally boost growth hormone. CJC-1295 increases the amplitude of GH release, while
Ipamorelin triggers frequent pulses — together creating a powerful synergy. This stack is commonly used
in performance, fat-loss, longevity, and recovery protocols for its safe, physiologic support of the GH/IGF-1
axis.
📚
CJC-1295 (no DAC) + Ipamorelin 3-Month Dosing Guide (1:1 Reconstitution)
Victory Peptides – We keep peptide reconstitution simple.
With a 1:1 ratio (10 mg powder + 1 mL water = 10 mg/mL),
the math is easy: 1 mg = 10 units on a U-100 insulin syringe.
Cycling Guidance:
At Victory Peptides, we recommend structured cycles for CJC-1295 (no DAC) + Ipamorelin:
- Run 8–12 weeks on-cycle (3 months)
- Then take 2–4 weeks off-cycle before resuming
- Best injected subcutaneously 2–3x daily, spaced 3–4 hours apart, on an empty stomach
- Morning, post-workout, and before bed are the most effective timing windows
- Pairs synergistically with Tesamorelin or AOD9604 for enhanced body composition changes.
Store the reconstituted solution at 2-8°C (refrigerator), protected from light.
Overview & Benefits
Promotes fat loss, lean muscle growth, and faster recovery through GH synergy
Improves sleep quality, skin health, and anti-aging outcomes
Stacks well with Tesamorelin, IGF-1 LR3, and Epithalon for advanced longevity and body
composition protocols
Improves sleep quality, skin health, and anti-aging outcomes
Stacks well with Tesamorelin, IGF-1 LR3, and Epithalon for advanced longevity and body
composition protocols
Snap 8
Reduces the depth of wrinkles caused by facial expressions
Supports smoother skin and improved texture
Stacks well with GHK-Cu, Argireline, and Hyaluronic Acid in skincare protocols
Supports smoother skin and improved texture
Stacks well with GHK-Cu, Argireline, and Hyaluronic Acid in skincare protocols
💉 Dosing Protocol
This protocol involves a single daily injection with gradual titration:
- Daily Dose: Begin with 400 mcg (10 units) and increase to 1,200 mcg (30 units) as tolerated
- Injection Frequency: Once daily, preferably at the same time each day
- Cycle Length: 12 weeks (adjustable based on research parameters)
- Note: Ensure consistent dosing intervals and accurate measurement using a 100-unit insulin syringe